Bend Biomedical has four primary disease targets for mass drug administration in blister packs: lymphatic filariasis, onchocerciasis, soil-transmitted helminths (ascariasis, trichuriasis, and hookworm infection), and under-five mortality (sub-Saharan Africa only).

Over one billion people are afflicted by one or more of these diseases in the regions of Africa, Central America, South America, the Middle East, South Asia, and Southeast Asia.

Our medicines also treat or prevent other diseases as extended targets, including tropical pulmonary eosinophilia, scabies, strongyloidiasis, mansonelliasis, malaria transmission, oesophagostomiasis, trachoma, and yaws.

Primary Targets:

Extended Targets: